Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohamed Jaber

Diagnostic Radiology Detroit, MI Medical Doctor

NPI 1942598990 CMS profile 732307

3990 John R St, Detroit, MI 48201

Open in the dashboard

General payments

$13,762

210 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mohamed Jaber of Detroit, MI is reported in the CMS Open Payments database as having received $13,762 across 210 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,448 33
2024 General $4,545 45
2023 General $956 38
2022 General $2,133 31
2021 General $1,072 22
2020 General $1,926 20
2019 General $682 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohamed Jaber
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Mohamed Jaber were reported at $2,448. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Mohamed Jaber Diagnostic Radiology median Middle half National median
2019 $682 $108 $29–$318 $163
2020 $1,926 $65 $21–$252 $114
2021 $1,072 $92 $24–$292 $132
2022 $2,133 $104 $29–$294 $149
2023 $956 $110 $29–$337 $160
2024 $4,545 $113 $30–$356 $164
2025 $2,448 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $4,829 62 payments
  2. Medtronic USA, Inc. $1,860 16 payments
  3. Terumo Medical Corporation $1,599 15 payments
  4. Relievant Medsystems, Inc. $1,342 5 payments
  5. Medtronic, Inc. $1,064 34 payments
  6. Boston Scientific Corporation $929 21 payments
  7. Stryker Corporation $743 16 payments
  8. Penumbra, Inc. $389 6 payments
  9. EKOS Corporation $169 5 payments
  10. Biogen, Inc. $124 1 payment
  11. Other $713 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,145 197 payments
  2. Travel and Lodging $3,617 12 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $5,128 69 payments
  2. CT THROMBECTOMY SYSTEM KIT $5,012 63 payments
  3. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $1,701 12 payments
  4. Intracept Pain $1,342 5 payments
  5. Intracept Pain $1,342 5 payments
  6. GLIDESHEATH SLENDER $1,226 7 payments
  7. KYPHON EXPRESS II KYPHOPAK TRAY $537 23 payments
  8. EkoSonic $466 7 payments
  9. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $306 6 payments
  10. Azur CX Detachable $247 4 payments
  11. Other $3,069 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 181 billing codes

Paid by Medicare

$82,214

Medicare's payments for the services billed

Medicare patients

863

Average age 74

Services billed

1,619

489 women, 374 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 41%
Chronic kidney disease 38%
Diabetes 37%
COPD 37%
Atrial fibrillation 31%
Heart failure 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

210 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record